What Happened?
Stony Brook, NY-based Black Diamond Therapeutics Appointed Elizabeth Montgomery as Chief People Officer
Date of management change: February 22, 2022
Stony Brook, NY-based Black Diamond Therapeutics Appointed Elizabeth Montgomery as Chief People Officer
Black Diamond Therapeutics is a next-wave cancer precision medicine company. Black Diamond pioneered the development of selective medicines for patients with genetically defined cancers driven by oncogenes activated by allosteric mutations. Using its mutation, allostery, and pharmacology (MAP) computational and discovery platform, Black Diamond is uncovering new ways to functionally assess the mutational landscape of individual oncogenes – to discover and validate new targets and develop novel approaches to creating highly selective therapeutics. Black Diamond was founded by David M. Epstein, Ph.D., Elizabeth Buck, Ph.D., and Versant Ventures, and is the first new company to emerge from Versant`s Ridgeline Discovery Engine in Basel, Switzerland.
Elizabeth Montgomery is Chief People Officer at Black Diamond Therapeutics. Previously, Elizabeth held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Talwar Bhavna, Roger Rachel, Duato Mark, Rogers Rose, Holmes Matt, Johnson Karen, Pritchard Julie, Bargeron Christopher, Kauffman Milbury Rebecca, Gelman Anatoliy, Cohen David
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.